CiRC Biosciences
A privately held, cell therapy company, developing treatments for serious diseases, with an initial focus on the eye.
Chicago, United States
12 employees
Debt Financing
Total: $23.84M
Biotechnology, Health and Wellness +1
General Information
Chicago, United States
BounceWatch is an independent company data service, not affiliated with CiRC Biosciences. To contact CiRC Biosciences, visit circbiosciences.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About CiRC Biosciences
Taxonomy: Cell Therapy, Regenerative Medicine, Retinal Diseases, Vision Restoration, Pre-clinical Development, Retinitis Pigmentosa, Dry Age-related Macular Degeneration, Portfolio Company, Paragon Biosciences
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | $7.00M | - |
|
01 May 2024 |
| Venture Round | $16.84M | - |
|
04 Dec 2020 |
CiRC Biosciences Alternatives & Competitors
Optogenetic Gene Therapy Company
Transforming Vision, Transforming Lives
Led by a team of seasoned veterans, RetroSense Therapeutics was founded in 2009 to develop a novel g...
FAQ About CiRC Biosciences
Source: BounceWatch company record for CiRC Biosciences, https://bouncewatch.com/company/circ-biosciences, updated 11 October 2024. When citing, please name BounceWatch and link this page.
